Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped ...
GLP-1 drugs such as Wegovy, Ozempic, and Zepbound are a class of medications primarily taken to treat Type 2 diabetes and, more recently, obesity. Research indicates many people taking GLP-1s for ...
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new ...
Still, GLP-1 medications may have benefits far beyond weight loss – for heart and liver health, for example – which may extend even to people who don’t lose as many pounds as they might have ...
Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t continue long enough to see meaningful health benefits, according to a study of people covered by ...
(CNN) — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss ...
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. Injectable GLP-1 medication can help manage ...
Share on Pinterest Metabolic and bariatric surgery is more effective for long-term weight loss than lifestyle changes and GLP-1 medications like Ozempic, Wegovy, and Zepbound. Nastasic/Getty ...
Researchers found lifestyle interventions such as diet and exercise resulted in an average weight loss of 7.4% but that weight was generally regained within 4.1 years. GLP-1s and metabolic and ...